Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers

British Journal of Clinical Pharmacology

Volumn 49, Issue SUPPL. 1, 2000, Pages 15-20

  Wilner, K D ^a   Tensfeldt, T G ^a   Baris, B ^a   Smolarek, T A ^a   Turncliff, R Z ^a   Colburn, W A ^b   Hansen, R A ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b Harris Laboratories Inc Phoenix   (United States)

Author keywords

Age; Gender; Pharmacokinetics; Schizoaffective; Schizophrenia; Ziprasidone

Indexed keywords

QUETIAPINE; ZIPRASIDONE;

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CLINICAL TRIAL; DRUG DOSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 0034015674     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00148.x     Document Type: Article

References (6)

1. Miceli JJ, Wilner KD, Hansen RA, et al. Single- and multiple-dose pharmacokinetics under non-fasting conditions in healthy male volunteers. Br J Clin Pharmacol 2000; 49(Suppl. 1): 5S-13S.
2. Howard HR, Lowe JA, Seeger TF, et al. 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. J Med Chem 1996; 39: 143-148.
3. Metropolitan height and weight tables. Stat Bull Metrop Life Found 1983; 64: 3-9.
4. Janiszewski JS, Fouda HG, Cole RO. Development and validation of a high-sensitivity assay for an antipsychotic agent, CP-88,059, with solid-phase extraction and narrow-bore high-performance liquid chromatography. J Chromatogr 1995; 668: 133-139.
5. Snoeck E, Van Peer A, Sack M. Influence of age, renal and liver impairment on the pharmacokinetics or risperidone. Psychopharmacology 1995; 122: 223-229.
6. Wong YWJ, Ewing BJ, Thrum PT. Multiple-dose pharmacokinetics of 'Seroquel' (quetiapine) in elderly psychotic patients. Schizophrenia Res 1997; 24: 199-200.